• BioMedTech
  • Fintech
  • Contact
  • LinkedIn
  • YouTube

Truffle Capital News

Denis Gestin appointed as Chairman of Holistick Medical – first startup funded by Truffle Capital’s BioMedTech Crossover Fund

October 10, 2018

Download PDF
brand_holistik_medical_png_.png

Holistick Medical

Patent Foramen Ovale (PFO) treatment through next generation medical devices

ALSO TO BE DISCOVERED

October 8, 2018

Truffle Capital announces exclusive and global License Agreement between Yale University and its newly created French start-up Nanosive

October 2, 2018

STRATEGIC PARTNERSHIP BETWEEN DEINOVE AND SOLVAY FOR THE MARKETING OF PHYTOENE IN NORTH AMERICA AND ASIA

September 20, 2018

Vincent Gardès, former CEO of VEXIM, joins Truffle Capital

September 4, 2018

Abivax reports impressive results in clinical phase 2a trial of ABX464 as an oral treatment for ulcerative colitis patients

August 29, 2018

CARMAT announces the certification of its new automated manufacturing site in Bois-d’Arcy for the production of up to 800 units a year at full capacity

August 2, 2018

CARMAT confirms the first successful heart transplant of a patient previously implanted with its total artificial heart

July 6, 2018

Acceleration of CARBIOLICE developments and second financing round led by the project partners

April 16, 2018

DEINOVE AND GREENTECH ANNOUNCE THE LAUNCH OF HEBELYS®, THE FIRST COSMETIC ACTIVE INGREDIENT RESULTING FROM THEIR COLLABORATION

April 12, 2018

CARBIOS achieves a major milestone in the optimization of its biorecycling process of PET based plastics

March 15, 2018

Truffle Capital’s newly created start-up HoliStick Medical licenses technology from Harvard University and collaborators

62 Rue de Miromesnil, 75008 Paris, France

T. +33 1 82 28 46 00

E. contact@truffle.com

  • Truffle
  • Biomedtech
  • Fintech
  • Regulatory Information
  • ESG
  • Contact
  • Legal notices
  • LinkedIn
  • YouTube

Business Builders